Sodium channels in pain disorders: pathophysiology and prospects for treatment

Pain. 2017 Apr;158 Suppl 1(Suppl 1):S97-S107. doi: 10.1097/j.pain.0000000000000854.

Authors

Sulayman D Dib-Hajj¹, Paul Geha, Stephen G Waxman

Affiliation

¹ aDepartment of Neurology, Yale University School of Medicine, New Haven, CT, USA bCenter for Neuroscience and Regeneration Research, Yale University School of Medicine, New Haven, CT, USA cRehabilitation Research Center, Veterans Affairs Connecticut Healthcare System, West Haven, CT, USA dDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT, USA eThe John B. Pierce Laboratory, New Haven, CT, USA.

No abstract available

Publication types

Review

MeSH terms

Animals
Humans
Nociceptors / drug effects
Sodium Channel Blockers / therapeutic use
Sodium Channels / genetics
Sodium Channels / metabolism*
Somatoform Disorders / drug therapy
Somatoform Disorders / genetics
Somatoform Disorders / metabolism*
Somatoform Disorders / physiopathology*

Substances

Sodium Channel Blockers
Sodium Channels

Grants and funding